Proniras Corp: Funding, Investors & Team (Oct 2026)
Proniras Corp is an operator of a biomedical company intended to develop drugs. The company's biomedical service has already demonstrated preclinical efficacy in treating nerve agent-induced seizures, as well as in studies of rodents exposed to the chemical weapon soman, which is more toxic than sarin gas, enabling medical researchers to continue their research work and discover drugs. It was founded in 2016 and is headquartered in Seattle, Washington.
Proniras Corp has raised $4.7M across 1 funding round on record, the most recent a Series B of $4.7M announced in Feb 2024.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Proniras Corp Company Profile and Key Stats
Latest funding round on record: Feb 2024.
Proniras Corp Funding Rounds
Proniras Corp Founders and Leadership Team
No contact details are on record for this team yet.
Proniras Corp Funding Compared to Other Biotechnology Startups
Proniras Corp's latest round of $4.7M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Proniras Corp in Biotechnology and Seattle
Companies Similar to Proniras Corp
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Proniras Corp Funding FAQs
What does Proniras Corp do?
Proniras Corp is an operator of a biomedical company intended to develop drugs. The company's biomedical service has already demonstrated preclinical efficacy in treating nerve agent-induced seizures, as well as in studies of rodents exposed to the chemical weapon soman, which is more toxic than sarin gas, enabling medical researchers to continue their research work and discover drugs. It was founded in 2016 and is headquartered in Seattle, Washington.
How much funding has Proniras Corp raised?
Proniras Corp has raised $4.7M across 1 round on record. The most recent is a Series B of $4.7M announced in Feb 2024.
When did Proniras Corp last raise funding?
Proniras Corp's most recent funding round on record is a Series B of $4.7M, announced in Feb 2024.
Who founded Proniras Corp?
FundedIQ lists Christopher Toombs (Founder) at Proniras Corp.
Where is Proniras Corp headquartered?
Proniras Corp is based in Seattle, Washington, United States.
How many employees does Proniras Corp have?
Proniras Corp is in the 1-10 employee band.
How does Proniras Corp's funding compare to other Biotechnology startups?
Proniras Corp's latest round of $4.7M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Proniras Corp Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Proniras Corp is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.